Drug Discovery and Development

Friday, May 3, 2019: 5:30 PM-7:00 PM
Room: 710 (Palais des congres de Montreal)
5:30 PM
208.176
176 Augmenting mGluR5 Activity Ameliorates Behavior Deficits in a Transgenic Rat Model of Autism Spectrum Disorder
R. Mittal M. M. Perdomo H. Marwede E. J. Horesh J. Mittal A. A. Eshraghi
5:30 PM
208.177
177 Polypharmacy and Medication Monitoring Among Children and Youth with ASD
K. J. Hewitt C. Ritter C. A. McMorris
5:30 PM
208.178
178 The Utility of Omnibus Statistical Approaches in Go/No-Go Decision Making in a Phase 2 Study in Adolescents with Autism Spectrum Disorder: A Case Example
E. Anagnostou J. P. Horrigan A. Yaroshinsky
See more of: Drug Discovery and Development
<< Previous Panel | Next Panel >>